Russell Frank Company’s Integra LifeSciences IART Stock Holding History

Russell Frank Company’s Portfolio IART Stock Details IART Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	$17.7M	Sell	526,318 -135,290	-20%	-$4.21M	0.03%	642
2015 Q4	$22.6M	Sell	661,608 -14,928	-2%	-$467K	0.04%	506
2015 Q3	$20.1M	Sell	676,536 -135,331	-17%	-$4.23M	0.04%	540
2015 Q2	$22.4M	Buy	811,867 +203,799	+34%	+$5.43M	0.04%	569
2015 Q1	$15.3M	Sell	608,068 -70,865	-10%	-$1.68M	0.03%	687
2014 Q4	$15.1M	Buy	678,933 +37,774	+6%	+$766K	0.03%	699
2014 Q3	$13M	Buy	641,159 +61,984	+11%	+$1.23M	0.02%	766
2014 Q2	$11.1M	Buy	579,175 +84,961	+17%	+$1.58M	0.02%	852
2014 Q1	$9.29M	Buy	494,214 +129,587	+36%	+$2.5M	0.02%	932
2013 Q4	$7.1M	Buy	364,627 +171,867	+89%	+$3.15M	0.01%	1035
2013 Q3	$3.17M	Buy	192,760 +94,598	+96%	+$1.52M	0.01%	1604
2013 Q2	$1.47M	Buy	+98,162	New	+$1.44M	﹤0.01%	1917

Other funds holding IART

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

SAM

Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return

Russell Frank Company's IART Position: Q1 2016 in Review

Russell Frank Company reduced its Integra LifeSciences (IART) stake by 20% in Q1 2016, selling an estimated $4.21M and leaving 526,318 shares worth $17.7M. The position accounts for 0.03% of the portfolio, ranked #642.

Russell Frank Company first reported a position in IART in Q2 2013 and has held it in 12 quarters since. The position peaked at $22.6M in Q4 2015. 194 funds tracked by Wall St. Rank hold IART as of Q1 2016.

Russell Frank Company held 526,318 shares of Integra LifeSciences worth $17.7M as of Q1 2016.
Russell Frank Company sold 135,290 Integra LifeSciences shares in Q1 2016, an estimated $4.21M.
Integra LifeSciences made up 0.03% of Russell Frank Company's portfolio in Q1 2016, its #642 holding.
Russell Frank Company first reported a position in Integra LifeSciences in Q2 2013 and has held it in 12 quarters since.
Russell Frank Company's Integra LifeSciences position peaked at $22.6M in Q4 2015.
194 funds tracked by Wall St. Rank held Integra LifeSciences as of Q1 2016.

Based on Russell Frank Company's 13F filing for Q1 2016, filed 29 Apr 2016.